CompaniesrMark Bio

rMark Bio

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

60

By Phase

PHASE4: 1

By Status

COMPLETED: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2021

2022

2023

2024

2025

2026

Today

Hover over trial bars to see details

Recent Trials

NCT05553587Lead Sponsor

Symptoms and Physiological Effects of Amara in Functional Dyspepsia

PHASE4Completed

60 participants

Started: Jul 22, 2022 · Completed: Apr 30, 2025

Funding History (4)

D/A

Oct 14, 2020

D

Oct 16, 2019

D/A

Sep 10, 2018

D

Feb 5, 2018

Related Companies

Within3

acquired